Massimo Simion

Title: Massimo Simion - Innovator in Maxillofacial Bone Augmentation

Introduction

Massimo Simion is a notable inventor based in Milan, Italy. He has made significant contributions to the field of maxillofacial surgery through his innovative approaches to bone augmentation. His work focuses on enhancing the methods and materials used in this critical area of medical science.

Latest Patents

Massimo Simion holds a patent for "Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix." This invention provides effective new methods and materials for maxillofacial bone augmentation, particularly for alveolar ridge augmentation. The patent addresses issues associated with prior art methods by utilizing human recombinant platelet-derived growth factor (rhPDGF-BB) combined with a biocompatible matrix. The materials also include a deproteinized bone block or calcium phosphate, along with a bioresorbable membrane. This innovative approach is effective in regenerating maxillofacial bones and facilitating the achievement of stable osseointegrated implants.

Career Highlights

Massimo Simion is associated with Biomimetic Therapeutics, LLC, where he continues to advance his research and development in the field of maxillofacial surgery. His work has garnered attention for its potential to improve patient outcomes in bone augmentation procedures.

Collaborations

Massimo has collaborated with notable professionals in his field, including Samuel E. Lynch and Myron Nevins. These collaborations have contributed to the advancement of techniques and materials used in maxillofacial surgery.

Conclusion

Massimo Simion's innovative contributions to maxillofacial bone augmentation highlight his commitment to improving surgical methods and patient care. His patent reflects a significant advancement in the field, showcasing the potential for enhanced outcomes in maxillofacial procedures.